{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T18:59:48Z","timestamp":1778007588911,"version":"3.51.4"},"reference-count":169,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/j.ecl.2007.06.002","type":"journal-article","created":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T08:57:35Z","timestamp":1185958655000},"page":"617-656","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Hyperthyroidism"],"prefix":"10.1016","volume":"36","author":[{"given":"Bindu","family":"Nayak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven P.","family":"Hodak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ecl.2007.06.002_bib1","series-title":"Williams' textbook of endocrinology","first-page":"374","article-title":"Thyrotoxicosis","author":"Larsen","year":"2002"},{"key":"10.1016\/j.ecl.2007.06.002_bib2","first-page":"483","article-title":"The spectrum of thyroid disease in a community","volume":"7","author":"Turnbridge","year":"1977","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"10.1016\/j.ecl.2007.06.002_bib3","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1365-2265.1990.tb03906.x","article-title":"Graves' disease following hyperthyroidism due to Hashimoto's disease: studies of eight cases","volume":"33","author":"Takasu","year":"1990","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"10.1016\/j.ecl.2007.06.002_bib4","first-page":"473","article-title":"Studies on the occurrence of ophthalmopathy in Graves' disease","volume":"120","author":"Marcocci","year":"1989","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"5","key":"10.1016\/j.ecl.2007.06.002_bib5","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2165\/00128071-200506050-00003","article-title":"Pretibial myxedema: pathophysiology and treatment options","volume":"6","author":"Fatourechi","year":"2005","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.ecl.2007.06.002_bib6","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0889-8529(05)70132-8","article-title":"Understanding the immunology of Graves' ophthalmopathy: is it an autoimmune disease?","volume":"29","author":"Bahn","year":"2000","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.ecl.2007.06.002_bib7","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1210\/jcem-70-1-89","article-title":"Patients with endocrine ophthalmopathy not associated with overt thyroid disease have multiple thyroid immunological abnormalities","volume":"70","author":"Salvi","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ecl.2007.06.002_bib8","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1210\/er.2002-0020","article-title":"Current perspective on the pathogenesis of Graves' disease and ophthalmopathy","volume":"24","author":"Prabhakar","year":"2003","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ecl.2007.06.002_bib9","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1172\/JCI111642","article-title":"Dexamethasone regulation of glycosaminoglycan synthesis cultured human fibroblasts: similar effects of glucocorticoid and thyroid hormone therapy","volume":"64","author":"Smith","year":"1984","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.ecl.2007.06.002_bib10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0889-8529(05)70295-4","article-title":"Clinical and laboratory diagnosis of thyrotoxicosis","volume":"27","author":"Dabon-Almirante","year":"1998","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.ecl.2007.06.002_bib11","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0140-6736(93)92990-B","article-title":"Pretibial myxedema: a manifestation of lymphoedema?","volume":"341","author":"Bull","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.ecl.2007.06.002_bib12","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1210\/jcem-27-5-595","article-title":"Therapy with occlusive dressings of pretibial myxedema with fluocinolone acetonide","volume":"27","author":"Kriss","year":"1967","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2007.06.002_bib13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2340\/00015555726971","article-title":"Successful treatment of chronic skin diseases with clobetasol propionate and a hydrocolloid occlusive dressing","volume":"72","author":"Volden","year":"1992","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"10.1016\/j.ecl.2007.06.002_bib14","first-page":"438","article-title":"Dermopathy of Graves' disease (pretibial myxedema)","volume":"87","author":"Schwartz","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ecl.2007.06.002_bib15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2165\/00128071-200304050-00003","article-title":"Cutaneous manifestations of endocrine disorders","volume":"4","author":"Jabbour","year":"2003","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.ecl.2007.06.002_bib16","first-page":"2270","article-title":"Activating thyrotropin receptor mutations are present in nonadenomatous hyperfunctioning nodules of toxic or autonomous multinodular goiter","volume":"85","author":"Tonacchera","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2007.06.002_bib17","first-page":"547","article-title":"Functional characteristics of three new germline mutations of the thyrotropin receptor gene causing autosomal dominant toxic thyroid hyperplasia","volume":"81","author":"Tonacchera","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ecl.2007.06.002_bib18","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1210\/jc.2002-021799","article-title":"Clinical features and outcome of subacute thyroiditis in an incidence cohort: Olmstead County, Minnesota, study","volume":"88","author":"Fatourechi","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2007.06.002_bib19","first-page":"1","article-title":"Persistent thyroid autoimmunity after subacute thyroiditis","volume":"23","author":"Weetman","year":"1987","journal-title":"J Clin Lab Immunol"},{"key":"10.1016\/j.ecl.2007.06.002_bib20","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF02121755","article-title":"Isolation and some serological and epidemiological data on the viruses recovered from patients with subacute thyroiditis de Quervain","volume":"161","author":"Stancek","year":"1975","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.ecl.2007.06.002_bib21","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/BF03348138","article-title":"High prevalence of subacute thyroiditis during summer season in Italy","volume":"10","author":"Martino","year":"1987","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ecl.2007.06.002_bib22","series-title":"Werner's and Ingbar's the thyroid","first-page":"536","article-title":"Subacute thyroiditis and acute infectious thyroiditis","author":"Farwell","year":"2005"},{"issue":"26","key":"10.1016\/j.ecl.2007.06.002_bib23","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1056\/NEJMra021194","article-title":"Thyroiditis","volume":"348","author":"Pearce","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ecl.2007.06.002_bib24","first-page":"67","article-title":"Transitory subclinical and permanent hypothyroidism in the course of subacute thyroiditis (de Quervain)","volume":"106","author":"Lio","year":"1984","journal-title":"Acta Endocrinol"},{"key":"10.1016\/j.ecl.2007.06.002_bib25","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1001\/archinte.142.13.2281","article-title":"Lymphocytic thyroiditis with spontaneously resolving hyperthyroidism (silent thyroiditis) and subacute thyroiditis: long-term follow-up","volume":"142","author":"Nikolai","year":"1982","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ecl.2007.06.002_bib26","series-title":"Werner's and Ingbar's the thyroid","first-page":"524","article-title":"Sporadic and postpartum thyroiditis","author":"Lazarus","year":"2005"},{"issue":"9","key":"10.1016\/j.ecl.2007.06.002_bib27","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1210\/jc.2002-020524","article-title":"Postpartum thyroiditis","volume":"87","author":"Stagnaro-Green","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.ecl.2007.06.002_bib28","first-page":"2455","article-title":"Thyroiditis after pregnancy loss","volume":"82","author":"Marqusee","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2007.06.002_bib29","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF03348726","article-title":"Prevalence and characteristics of post-partum thyroid dysfunction: results of a survey from Toronto, Canada","volume":"15","author":"Walfish","year":"1992","journal-title":"J Endocrinol Invest"},{"issue":"10","key":"10.1016\/j.ecl.2007.06.002_bib30","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1089\/thy.2005.15.1177","article-title":"Postpartum thyroiditis: long-term follow-up","volume":"15","author":"Lucas","year":"2005","journal-title":"Thyroid"},{"issue":"418","key":"10.1016\/j.ecl.2007.06.002_bib31","first-page":"305","article-title":"Clinical aspects of recurrent postpartum thyroiditis","volume":"47","author":"Lazarus","year":"1997","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.ecl.2007.06.002_bib32","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1365-2265.2001.01381.x","article-title":"Association between lithium use and thyrotoxicosis caused by silent thyroiditis","volume":"55","author":"Miller","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2007.06.002_bib33","doi-asserted-by":"crossref","first-page":"178","DOI":"10.7326\/0003-4819-115-3-178","article-title":"Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors","volume":"115","author":"Ronnblom","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ecl.2007.06.002_bib34","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1046\/j.1365-2265.2002.01553.x","article-title":"Thyrotoxicosis induced by alpha-interferon therapy in chronic viral hepatitis","volume":"56","author":"Wong","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2007.06.002_bib35","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1093\/clinchem\/35.9.1882","article-title":"Amiodarone and the thyroid","volume":"35","author":"Kennedy","year":"1989","journal-title":"Clin Chem"},{"issue":"1","key":"10.1016\/j.ecl.2007.06.002_bib36","doi-asserted-by":"crossref","first-page":"63","DOI":"10.7326\/0003-4819-126-1-199701010-00009","article-title":"Effects of amiodarone on thyroid function","volume":"126","author":"Harjai","year":"1997","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.ecl.2007.06.002_bib37","doi-asserted-by":"crossref","first-page":"28","DOI":"10.7326\/0003-4819-101-1-28","article-title":"Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy","volume":"101","author":"Martino","year":"1984","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ecl.2007.06.002_bib38","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11102-005-3759-4","article-title":"Clinical and molecular features of a TSH-secreting pituitary macroadenoma","volume":"8","author":"Usui","year":"2005","journal-title":"Pituitary"},{"issue":"2","key":"10.1016\/j.ecl.2007.06.002_bib39","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1210\/jcem.84.2.5505","article-title":"Thyrotropin-secreting pituitary tumors: diagnostic criteria, thyroid hormone sensitivity, and treatment outcome in 25 patients followed at the National Institutes of Health","volume":"84","author":"Brucker-Davis","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2007.06.002_bib40","series-title":"Werner's and Ingbar's the thyroid: a fundamental and clinical text","first-page":"1109","article-title":"Resistance to thyroid hormone","author":"Refetoff","year":"2005"},{"key":"10.1016\/j.ecl.2007.06.002_bib41","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1258\/000456306778904678","article-title":"Thyroid hormone resistance","volume":"43","author":"Olateju","year":"2006","journal-title":"Ann Clin Biochem"},{"issue":"8","key":"10.1016\/j.ecl.2007.06.002_bib42","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1093\/clinchem\/37.8.1430","article-title":"Prevalence of familial dysalbuminemic hyperthyroxinemia in serum samples received for thyroid testing","volume":"37","author":"Arevalo","year":"1991","journal-title":"Clin Chem"},{"key":"10.1016\/j.ecl.2007.06.002_bib43","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.0954-6820.1987.tb01282.x","article-title":"Familial dysalbuminemic hyperthyroxinemia","volume":"221","author":"Jensen","year":"1987","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.ecl.2007.06.002_bib44","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1210\/jcem-62-1-230","article-title":"Specific methods to identify plasma binding abnormalities in euthyroid hyperthyroxinemia","volume":"62","author":"Stockigt","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2007.06.002_bib45","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJM198704163161605","article-title":"An outbreak of thyrotoxicosis caused by the consumption of bovine thyroid gland in ground beef","volume":"316","author":"Hedberg","year":"1987","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ecl.2007.06.002_bib46","doi-asserted-by":"crossref","first-page":"112","DOI":"10.7326\/0003-4819-118-2-199301150-00006","article-title":"The use of bile acid sequestrants to lower serum thyroid hormones in iatrogenic hyperthyroidism","volume":"118","author":"Shakir","year":"1993","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.ecl.2007.06.002_bib47","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0020-7292(93)90628-A","article-title":"Struma ovarii","volume":"42","author":"Ayhan","year":"1993","journal-title":"Int J Gynecol Obstet"},{"issue":"10","key":"10.1016\/j.ecl.2007.06.002_bib48","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/00003072-200010000-00001","article-title":"Struma ovarii with hyperthyroidism","volume":"25","author":"Grandet","year":"2000","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.ecl.2007.06.002_bib49","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1006\/gyno.1999.5355","article-title":"Malignant struma ovarii: two case reports and a review of the literature","volume":"73","author":"Dardik","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ecl.2007.06.002_bib50","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00003072-199801000-00004","article-title":"I-123 uptake in nonfunctional struma ovarii","volume":"23","author":"Joja","year":"1998","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.ecl.2007.06.002_bib51","first-page":"943","article-title":"Conservative therapy for malignant struma ovarii: a case report","volume":"47","author":"Nahn","year":"2002","journal-title":"J Reprod Med"},{"key":"10.1016\/j.ecl.2007.06.002_bib52","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1210\/jcem-6-3-247","article-title":"Adenocarcinoma of the thyroid with hyperthyroidism and functional metastases","volume":"6","author":"Leiter","year":"1946","journal-title":"J Clin Endocrinol"},{"key":"10.1016\/j.ecl.2007.06.002_bib53","series-title":"Thyroid cancer: a comprehensive guide to clinical management","first-page":"387","article-title":"Special presentations of thyroid cancer in pregnancy, renal failure, thyrotoxicosis, and struma ovarii","author":"Burman","year":"2006"},{"key":"10.1016\/j.ecl.2007.06.002_bib54","series-title":"Werner's and Ingbar's the thyroid","first-page":"548","article-title":"Thyrotoxicosis of extrathyroid origin","author":"Pearce","year":"2005"},{"key":"10.1016\/j.ecl.2007.06.002_bib55","series-title":"Werner's and Ingbar's the thyroid","first-page":"660","article-title":"Thyrotoxic storm","author":"Wartofsky","year":"2005"},{"issue":"4","key":"10.1016\/j.ecl.2007.06.002_bib56","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/00006842-197906000-00007","article-title":"Emotional disturbance and cognitive deficits in hyperthyroidism","volume":"41","author":"MacCrimmon","year":"1979","journal-title":"Psychosom Med"},{"issue":"3","key":"10.1016\/j.ecl.2007.06.002_bib57","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1210\/jcem-41-3-491","article-title":"Metabolic clearance and blood production rates of estradiol in hyperthyroidism","volume":"41","author":"Ridgway","year":"1975","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2007.06.002_bib58","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1677\/joe.0.0950105","article-title":"Androgen and oestrogen dynamics in hyperthyroidism","volume":"95","author":"Ridgway","year":"1982","journal-title":"J Endocrinol"},{"issue":"5","key":"10.1016\/j.ecl.2007.06.002_bib59","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1089\/thy.1996.6.505","article-title":"Acute effects of thyroid hormone on vascular smooth muscle","volume":"6","author":"Ojamaa","year":"1996","journal-title":"Thyroid"},{"issue":"7","key":"10.1016\/j.ecl.2007.06.002_bib60","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJM200102153440707","article-title":"Thyroid hormone and the cardiovascular system","volume":"344","author":"Klein","year":"2001","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ecl.2007.06.002_bib61","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0889-8529(05)70297-8","article-title":"Thyrotoxicosis and the heart","volume":"27","author":"Klein","year":"1998","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.ecl.2007.06.002_bib62","series-title":"Werner's and Ingbar's the thyroid","first-page":"660","article-title":"Diagnosis of thyrotoxicosis","author":"Ladenson","year":"2005"},{"issue":"1","key":"10.1016\/j.ecl.2007.06.002_bib63","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/105072503321086962","article-title":"Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease","volume":"13","author":"Baloch","year":"2003","journal-title":"Thyroid"},{"key":"10.1016\/j.ecl.2007.06.002_bib64","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jemermed.2004.08.020","article-title":"Thyroid disease in the emergency department: a clinical and laboratory review","volume":"28","author":"Pimental","year":"2005","journal-title":"J Emerg Med"},{"issue":"1","key":"10.1016\/j.ecl.2007.06.002_bib65","first-page":"90","article-title":"Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease","volume":"84","author":"Costagliola","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2007.06.002_bib66","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1055\/s-2005-921102","article-title":"Binding, stimulating and blocking TSH receptor antibodies to the thyrotropin receptor as predictors of relapse of Graves' disease after withdrawal of antithyroid treatment","volume":"37","author":"Quadbeck","year":"2005","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.ecl.2007.06.002_bib67","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1055\/s-2005-921099","article-title":"Relevance of TSH receptor stimulating and blocking autoantibody measurement for the prediction of relapse in Graves' disease","volume":"37","author":"Schott","year":"2005","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.ecl.2007.06.002_bib68","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2265.1994.tb03778.x","article-title":"Prediction of post-partum Graves' thyrotoxicosis by measurement of thyroid stimulating antibody in early pregnancy","volume":"41","author":"Hidaka","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.ecl.2007.06.002_bib69","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1055\/s-2007-999676","article-title":"Universal predictive criteria for neonatal overt thyrotoxicosis requiring treatment","volume":"5","author":"Tamaki","year":"1988","journal-title":"Am J Perinatol"},{"issue":"2","key":"10.1016\/j.ecl.2007.06.002_bib70","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2265.1990.tb00850.x","article-title":"Graves' disease in pregnancy: TSH receptor binding inhibiting immunoglobulins and maternal and neonatal thyroid function","volume":"32","author":"Mortimer","year":"1990","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2007.06.002_bib71","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.1980.03310170032021","article-title":"Thyroxine toxicosis: a common variant of hyperthyroidism","volume":"244","author":"Caplan","year":"1980","journal-title":"JAMA"},{"key":"10.1016\/j.ecl.2007.06.002_bib72","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1210\/jcem-53-1-113","article-title":"Serum ratio of triiodothyronine to thyroxine, and thyroxine-binding globulin and calcitonin concentrations in Graves' disease and destruction-induced thyrotoxicosis","volume":"53","author":"Amino","year":"1981","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2007.06.002_bib73","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1507\/endocrj.52.29","article-title":"Rapid differential diagnosis of Graves' disease and painless thyroiditis using T3\/T4 ratio, TSH, and total alkaline phosphatase activity","volume":"52","author":"Yanagisawa","year":"2005","journal-title":"Endocr\u00a0J"},{"key":"10.1016\/j.ecl.2007.06.002_bib74","doi-asserted-by":"crossref","first-page":"668","DOI":"10.7326\/0003-4819-84-6-668","article-title":"Ionized and total serum calcium and parathyroid hormone in hyperthyroidism","volume":"84","author":"Burman","year":"1976","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ecl.2007.06.002_bib75","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1023\/A:1022933918182","article-title":"Thyroid emergencies","volume":"4","author":"Sarlis","year":"2003","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.ecl.2007.06.002_bib76","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1210\/endo.134.1.8275930","article-title":"Osteoclasts mediate thyroid hormone stimulation of osteoclastic bone resorption","volume":"134","author":"Britto","year":"1994","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.ecl.2007.06.002_bib77","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1148\/rg.234025716","article-title":"Scintigraphic manifestations of thyrotoxicosis","volume":"23","author":"Intenzo","year":"2003","journal-title":"Radiographics"},{"issue":"2","key":"10.1016\/j.ecl.2007.06.002_bib78","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0889-8529(05)70188-2","article-title":"Radioactive iodine uptake and thyroid scintiscanning","volume":"30","author":"Meier","year":"2001","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"7","key":"10.1016\/j.ecl.2007.06.002_bib79","first-page":"1036","article-title":"Marine-Lenhart syndrome","volume":"97","author":"Cakir","year":"2005","journal-title":"J Natl Med Assoc"},{"key":"10.1016\/j.ecl.2007.06.002_bib80","series-title":"Werner's and Ingbar's the thyroid","first-page":"437","article-title":"In vivo isotopic tests and imaging","author":"Cavalieri","year":"1991"},{"key":"10.1016\/j.ecl.2007.06.002_bib81","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1148\/radiology.148.3.6308711","article-title":"Thyroid imaging agents: a comparison of I-123 and Tc-99m pertechnetate","volume":"148","author":"Ryu","year":"1983","journal-title":"Radiology"},{"issue":"11","key":"10.1016\/j.ecl.2007.06.002_bib82","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1089\/thy.2005.15.1249","article-title":"Measurement of thyroid blood flow area is useful for diagnosing the cause of thyrotoxicosis","volume":"15","author":"Kurita","year":"2005","journal-title":"Thyroid"},{"key":"10.1016\/j.ecl.2007.06.002_bib83","doi-asserted-by":"crossref","unstructured":"Bogazzi F, Bartalena L, Brogiani S. Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis. Thyroid 1997;7:541\u20135.","DOI":"10.1089\/thy.1997.7.541"},{"key":"10.1016\/j.ecl.2007.06.002_bib84","first-page":"195","article-title":"Chemotherapy of hyperthyroidism","volume":"40","author":"Astwood","year":"1945","journal-title":"Harvey Lect"},{"key":"10.1016\/j.ecl.2007.06.002_bib85","series-title":"Werner's and Ingbar's the thyroid","first-page":"665","article-title":"Treatment of thyrotoxicosis","author":"Cooper","year":"2005"},{"key":"10.1016\/j.ecl.2007.06.002_bib86","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/BF03343586","article-title":"Longitudinal study of soluble intracellular adhesion molecule-1 (ICAM-1) in sera of patients with Graves' disease","volume":"22","author":"Sonnet","year":"1999","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ecl.2007.06.002_bib87","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.1365-2362.1995.tb01981.x","article-title":"Increased serum interleukin-1 beta during treatment of hyperthyroidism with antithyroid drugs","volume":"25","author":"Tsatsoulis","year":"1995","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.ecl.2007.06.002_bib88","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1056\/NEJM198008073030603","article-title":"Carbimazole and the autoimmune response in Graves' disease","volume":"303","author":"McGregor","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ecl.2007.06.002_bib89","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1089\/105072501750302886","article-title":"Antithyroid drugs inhibit in vivo HLA-DR expression in thyroid follicular cells in Graves' disease","volume":"11","author":"Zantut-Wittman","year":"2001","journal-title":"Thyroid"},{"key":"10.1016\/j.ecl.2007.06.002_bib90","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1089\/105072504323150787","article-title":"Antithyroid drug-induced agranulocytosis: special reference to normal white blood cell count agranulocytosis","volume":"14","author":"Tajiri","year":"2004","journal-title":"Thyroid"},{"issue":"3","key":"10.1016\/j.ecl.2007.06.002_bib91","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1210\/jcem-57-3-563","article-title":"Comparison of effects of high and low dosage regimens of antithyroid drugs in the management of Graves' hyperthyroidism","volume":"57","author":"Romaldini","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ecl.2007.06.002_bib92","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1046\/j.1365-2265.1998.00466.x","article-title":"TSH suppression combined with carbimazole for Graves' disease: effect on remission and relapse rate","volume":"48","author":"Pujol","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.ecl.2007.06.002_bib93","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1530\/eje.0.1360081","article-title":"Suppression of serum thyrotropin with thyroxine in patients with Graves' disease: effects on recurrence of hyperthyroidism and thyroid volume","volume":"136","author":"Pfeilschifter","year":"1997","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.ecl.2007.06.002_bib94","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1056\/NEJM199601253340403","article-title":"Lack of effect of thyroxine in patients with Graves' hyperthyroidism who are treated with an antithyroid drug","volume":"334","author":"McIver","year":"1996","journal-title":"N Engl J of Med"},{"issue":"1","key":"10.1016\/j.ecl.2007.06.002_bib95","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1210\/jcem-63-1-125","article-title":"Treatment of hyperthyroidism with a single daily dose of methimazole","volume":"63","author":"Shiroozu","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.ecl.2007.06.002_bib96","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/00007611-199509000-00018","article-title":"Single daily dose of methimazole compared to every 8 hours propylthiouracil in the treatment of hyperthyroidism","volume":"88","author":"Nicholas","year":"1995","journal-title":"South Med J"},{"key":"10.1016\/j.ecl.2007.06.002_bib97","first-page":"13","article-title":"Single daily dose methimazole treatment of hyperthyroidism","volume":"132","author":"Bouma","year":"1980","journal-title":"West J Med"},{"key":"10.1016\/j.ecl.2007.06.002_bib98","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1365-2265.2004.02032.x","article-title":"Comparison of single daily dose methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism","volume":"60","author":"He","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2007.06.002_bib99","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1210\/jcem-43-1-152","article-title":"Effect of antithyroid agents 6-propyl-2-thiouracil and 1-methyl-2-mercaptoimidazole on human thyroid iodide peroxidase","volume":"43","author":"Nagasaka","year":"1976","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2007.06.002_bib100","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1210\/jcem-57-1-129","article-title":"Intrathyroidal concentrations of methimazole in patients with Graves' disease","volume":"57","author":"Jansson","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2007.06.002_bib101","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1210\/jcem-65-4-719","article-title":"Reevaluation of the effects of methylmercaptoimidazole and propylthiouracil in patients with Graves' hyperthyroidism","volume":"65","author":"Okamura","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2007.06.002_bib102","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0002-9343(90)90130-6","article-title":"Rectal administration of propylthiouracil in the treatment of Graves' disease","volume":"88","author":"Walter","year":"1990","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.ecl.2007.06.002_bib103","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1210\/jcem-54-1-180","article-title":"Methimazole: an alternative route of administration","volume":"54","author":"Nabil","year":"1982","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ecl.2007.06.002_bib104","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1089\/thy.1995.5.403","article-title":"Rectal administration of iodide and propylthiouracil in the treatment of thyroid storm","volume":"5","author":"Yeung","year":"1995","journal-title":"Thyroid"},{"issue":"7","key":"10.1016\/j.ecl.2007.06.002_bib105","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1089\/105072502320288500","article-title":"Rectal administration of propylthiouracil in hyperthyroid patients: comparison of suspension enema and suppository form","volume":"12","author":"Jongjaroenprasert","year":"2002","journal-title":"Thyroid"},{"key":"10.1016\/j.ecl.2007.06.002_bib106","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1507\/endocrj1954.33.605","article-title":"Pharmacokinetics of methimazole in normal subjects and hyperthyroid patients","volume":"33","author":"Okamura","year":"1986","journal-title":"Endocrinol Jpn"},{"issue":"7","key":"10.1016\/j.ecl.2007.06.002_bib107","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1089\/thy.2006.16.691","article-title":"Intravenous methimazole in the treatment of refractory hyperthyroidism","volume":"16","author":"Hodak","year":"2006","journal-title":"Thyroid"},{"key":"10.1016\/j.ecl.2007.06.002_bib108","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/00000441-198904000-00003","article-title":"Adverse effects related to thionamide drugs and their dose regimen","volume":"297","author":"Werner","year":"1989","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.ecl.2007.06.002_bib109","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1365-2265.2004.02135.x","article-title":"Spontaneous reporting of adverse reactions to carbimazole and propylthiouracil in the UK","volume":"61","author":"Pearce","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"10.1016\/j.ecl.2007.06.002_bib110","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1089\/thy.2005.15.292","article-title":"Antithyroid drug-induced agranulocytosis: how has granulocyte colony-stimulating factor changed therapy?","volume":"15","author":"Tajiri","year":"2005","journal-title":"Thyroid"},{"key":"10.1016\/j.ecl.2007.06.002_bib111","doi-asserted-by":"crossref","first-page":"26","DOI":"10.7326\/0003-4819-98-1-26","article-title":"Agranulocytosis associated with antithyroid drugs. Effects of patient age and drug dose","volume":"98","author":"Cooper","year":"1983","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ecl.2007.06.002_bib112","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0889-8529(05)70308-X","article-title":"Antithyroid drugs for the treatment of hyperthyroidism caused by Graves' disease","volume":"27","author":"Cooper","year":"1998","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.ecl.2007.06.002_bib113","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/qjmed\/92.8.455","article-title":"Antithyroid drug-induced agranulocytosis complicated by life-threatening infections","volume":"92","author":"Sheng","year":"1999","journal-title":"QJM"},{"key":"10.1016\/j.ecl.2007.06.002_bib114","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMra042972","article-title":"Antithyroid drugs","volume":"352","author":"Cooper","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ecl.2007.06.002_bib115","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1742-1241.1966.tb07084.x","article-title":"Management of thyrotoxicosis with a beta-adrenergic blocking agent","volume":"20","author":"Hughes","year":"1966","journal-title":"Br J Clin Pract"},{"key":"10.1016\/j.ecl.2007.06.002_bib116","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0889-8529(03)00010-0","article-title":"Perioperative management of the thyrotoxic patient","volume":"32","author":"Langley","year":"2003","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.ecl.2007.06.002_bib117","series-title":"Werner's and Ingbar's the thyroid","first-page":"51","article-title":"Hormone synthesis: thyroid iodine metabolism","author":"Taurog","year":"1991"},{"key":"10.1016\/j.ecl.2007.06.002_bib118","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0272-5231(03)00091-1","article-title":"Critical issues in endocrinology","volume":"24","author":"Goldberg","year":"2003","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.ecl.2007.06.002_bib119","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1210\/jc.2003-031981","article-title":"Rapid preoperative preparation for severe hyperthyroid Graves' disease","volume":"89","author":"Panzer","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2007.06.002_bib120","first-page":"174","article-title":"Lithium and iodine combination therapy for thyrotoxicosis","volume":"94","author":"Boehm","year":"1980","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"6","key":"10.1016\/j.ecl.2007.06.002_bib121","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1210\/jcem-35-6-905","article-title":"The inhibitory effect of lithium on thyroid hormone release in both euthyroid and thyrotoxic patients","volume":"35","author":"Spaulding","year":"1972","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2007.06.002_bib122","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2265.1993.tb00970.x","article-title":"Adjunctive cholestyramine therapy for thyrotoxicosis","volume":"38","author":"Solomon","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"9","key":"10.1016\/j.ecl.2007.06.002_bib123","first-page":"3191","article-title":"Treatment of hyperthyroidism with a combination of methimazole and cholestyramine","volume":"81","author":"Mercado","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ecl.2007.06.002_bib124","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1365-2265.2005.02249.x","article-title":"The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism","volume":"62","author":"Tsai","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"15","key":"10.1016\/j.ecl.2007.06.002_bib125","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/jnci\/83.15.1072","article-title":"Cancer risk after iodine-131 therapy for hyperthyroidism","volume":"83","author":"Holm","year":"1991","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ecl.2007.06.002_bib126","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/S0140-6736(98)12295-X","article-title":"Cancer incidence and mortality after radioactive iodine treatment for hyperthyroidism: a population-based cohort study","volume":"353","author":"Franklyn","year":"1999","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.ecl.2007.06.002_bib127","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1056\/NEJM198408163110702","article-title":"Long-term follow-up study of compensated low-dose 131I therapy for Graves' disease","volume":"311","author":"Sridama","year":"1984","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ecl.2007.06.002_bib128","first-page":"411","article-title":"Optimal iodine-131 dose for eliminating hyperthyroidism in Graves' disease","volume":"32","author":"Nordyke","year":"1991","journal-title":"J Nucl Med"},{"issue":"3","key":"10.1016\/j.ecl.2007.06.002_bib129","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1056\/NEJM197401172900306","article-title":"Low-dosage 131-I therapy of thyrotoxicosis (diffuse goiters). A five-year follow-up study","volume":"290","author":"Cevallos","year":"1974","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ecl.2007.06.002_bib130","series-title":"Conn's current therapy","first-page":"806","article-title":"Hyperthyroidism","author":"Burman","year":"2006"},{"issue":"2","key":"10.1016\/j.ecl.2007.06.002_bib131","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0002-9343(83)91217-2","article-title":"Radioactive iodine-induced thyroid storm. Case report and literature review","volume":"75","author":"McDermott","year":"1983","journal-title":"Am J Med"},{"issue":"9","key":"10.1016\/j.ecl.2007.06.002_bib132","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.1210\/jc.2004-0247","article-title":"Propylthiouracil before I-131 therapy of hyperthyroid diseases: effect on cure rate evaluated by a randomized clinical trial","volume":"89","author":"Bonnema","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2007.06.002_bib133","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1089\/1050725041517093","article-title":"Propylthiouracil reduces the effectiveness of radioactive iodine treatment in hyperthyroid patients with Graves' disease","volume":"14","author":"Santos","year":"2004","journal-title":"Thyroid"},{"issue":"8","key":"10.1016\/j.ecl.2007.06.002_bib134","first-page":"3488","article-title":"The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism: one-year follow-up of a prospective, randomized study","volume":"86","author":"Andrade","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.ecl.2007.06.002_bib135","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1210\/jc.2006-0226","article-title":"Continuous methimazole therapy and its effect on the cure rate of hyperthyroidism using radioactive iodine: an evaluation by a randomized trial","volume":"91","author":"Bonnema","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2007.06.002_bib136","first-page":"1229","article-title":"Success rate of radioactive iodine therapy in Graves' disease: the influence of thyrostatic medication","volume":"84","author":"Sabri","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2007.06.002_bib137","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1089\/thy.1997.7.369","article-title":"Clinical features of patients with Graves' disease undergoing remission after antithyroid drug treatment","volume":"7","author":"Vitti","year":"1997","journal-title":"Thyroid"},{"key":"10.1016\/j.ecl.2007.06.002_bib138","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2265.1989.tb01244.x","article-title":"Antithyroid drugs in the treatment of hyperthyroidism of Graves' disease: long-term follow-up of 434 patients","volume":"31","author":"Hedley","year":"1989","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.ecl.2007.06.002_bib139","first-page":"168","article-title":"Management of Graves' ophthalmopathy: reality and perspectives","volume":"21","author":"Bartalena","year":"2000","journal-title":"Endocr Rev"},{"issue":"9","key":"10.1016\/j.ecl.2007.06.002_bib140","doi-asserted-by":"crossref","first-page":"5234","DOI":"10.1210\/jc.2005-0148","article-title":"Randomized, single blind trial of intravenous versus oral steroid monotherapy in Graves' orbitopathy","volume":"90","author":"Kahaly","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2007.06.002_bib141","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM199801083380201","article-title":"Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy","volume":"338","author":"Bartalena","year":"1998","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.ecl.2007.06.002_bib142","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1056\/NEJM199206253262603","article-title":"Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism","volume":"326","author":"Tallstedt","year":"1992","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ecl.2007.06.002_bib143","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF03345276","article-title":"Relationship between cigarette smoking and Graves' ophthalmopathy","volume":"27","author":"Hegedius","year":"2004","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ecl.2007.06.002_bib144","doi-asserted-by":"crossref","first-page":"632","DOI":"10.7326\/0003-4819-129-8-199810150-00010","article-title":"Cigarette smoking and treatment outcomes in Graves' ophthalmopathy","volume":"129","author":"Bartalena","year":"1998","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.ecl.2007.06.002_bib145","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0889-8529(05)70304-2","article-title":"Toxic nodular goiter: toxic adenoma and toxic multinodular goiter","volume":"27","author":"Siegel","year":"1998","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"8","key":"10.1016\/j.ecl.2007.06.002_bib146","first-page":"2930","article-title":"Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study","volume":"81","author":"Bartalena","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2007.06.002_bib147","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF03348098","article-title":"Treatment of amiodarone associated thyrotoxicosis by simultaneous administration of potassium perchlorate and methimazole","volume":"9","author":"Martino","year":"1986","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ecl.2007.06.002_bib148","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/00007691-200108000-00002","article-title":"Perchlorate clinical pharmacology and human health: a review","volume":"23","author":"Soldin","year":"2001","journal-title":"Ther Drug Monit"},{"issue":"2","key":"10.1016\/j.ecl.2007.06.002_bib149","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1089\/105072503321319521","article-title":"A stepwise approach to the treatment of amiodarone-induced thyrotoxicosis","volume":"13","author":"Erdogan","year":"2003","journal-title":"Thyroid"},{"key":"10.1016\/j.ecl.2007.06.002_bib150","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1001\/archinte.1993.00410070068010","article-title":"Thyrotoxicosis followed by hypothyroidism in patients treated with amiodarone: a possible consequence of a destructive process of the thyroid","volume":"153","author":"Roti","year":"1993","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ecl.2007.06.002_bib151","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0002-9378(89)90088-4","article-title":"Thyrotoxicosis complicating pregnancy","volume":"160","author":"Davis","year":"1989","journal-title":"Am J\u00a0Obstet Gynecol"},{"key":"10.1016\/j.ecl.2007.06.002_bib152","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ecl.2005.09.009","article-title":"Thyroid disorders during pregnancy","volume":"35","author":"LeBeau","year":"2006","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"8","key":"10.1016\/j.ecl.2007.06.002_bib153","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1172\/JCI26031","article-title":"Thyrotropin receptor-associated diseases: from adenomata to Graves' disease","volume":"115","author":"Davies","year":"2005","journal-title":"J Clin Invest"},{"issue":"25","key":"10.1016\/j.ecl.2007.06.002_bib154","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1056\/NEJM199812173392505","article-title":"Familial gestational hyperthyroidism caused by a mutant thyrotropin receptor hypersensitive to human chorionic gonadotropin","volume":"339","author":"Rodien","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ecl.2007.06.002_bib155","first-page":"1333","article-title":"The role of chorionic gonadotropin in transient hyperthyroidism of hyperemesis gravidarum","volume":"75","author":"Goodwin","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2007.06.002_bib156","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1210\/edrv.18.4.0305","article-title":"Novel insights into the molecular mechanisms of human thyrotropin action: structural, physiological, and therapeutic implications for the glycoprotein hormone family","volume":"18","author":"Grossman","year":"1997","journal-title":"Endocr Rev"},{"issue":"3","key":"10.1016\/j.ecl.2007.06.002_bib157","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/01.ftd.0000211834.41844.82","article-title":"Thyroid medications during pregnancy","volume":"28","author":"Bach-Huynh","year":"2006","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.ecl.2007.06.002_bib158","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1210\/edrv-14-2-194","article-title":"Thyroid function and hyperfunction during gestation","volume":"14","author":"Burrow","year":"1993","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ecl.2007.06.002_bib159","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1089\/thy.1999.9.647","article-title":"Hyperthyroidism in pregnancy: diagnosis and treatment","volume":"9","author":"Masiukiewicz","year":"1999","journal-title":"Thyroid"},{"key":"10.1016\/j.ecl.2007.06.002_bib160","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1210\/jcem-45-6-1187","article-title":"The placental transfer of propylthiouracil, methimazole, and carbimazole","volume":"45","author":"Marchant","year":"1977","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2007.06.002_bib161","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1525-1470.1986.tb00534.x","article-title":"The association of aplasia cutis congenita with therapy of maternal thyroid disease","volume":"3","author":"Kalb","year":"1986","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.ecl.2007.06.002_bib162","doi-asserted-by":"crossref","first-page":"60","DOI":"10.7326\/0003-4819-106-1-60","article-title":"Methimazole, carbimazole, and congenital skin defects","volume":"106","author":"Van Dijke","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ecl.2007.06.002_bib163","first-page":"3099","article-title":"Methimazole and propylthiouracil equally cross the perfused human term placental lobule","volume":"82","author":"Mortimer","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2007.06.002_bib164","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJM198607033150104","article-title":"Antithyroid drug therapy for Graves' disease during pregnancy: optimal regimen for fetal thyroid status","volume":"315","author":"Momotani","year":"1986","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ecl.2007.06.002_bib165","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.beem.2004.03.005","article-title":"Hyperthyroidism in pregnancy","volume":"18","author":"Mestman","year":"2004","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.ecl.2007.06.002_bib166","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0002-9378(16)32785-5","article-title":"Surgery during pregnancy and fetal outcome","volume":"138","author":"Brodsky","year":"1980","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ecl.2007.06.002_bib167","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/00003081-199703000-00005","article-title":"Fetal thyroid function: diagnosis and management of fetal thyroid disorders","volume":"40","author":"Fisher","year":"1997","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.ecl.2007.06.002_bib168","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1056\/NEJM199102213240807","article-title":"Successful in utero treatment of fetal goiter and hypothyroidism","volume":"324","author":"Davidson","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ecl.2007.06.002_bib169","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/pd.1970150702","article-title":"In utero diagnosis and treatment of fetal goitrous hypothyroidism, caused by maternal use of propylthiouracil","volume":"15","author":"Van Loon","year":"1995","journal-title":"Prenat Diagn"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852907000588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852907000588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:31:04Z","timestamp":1760175064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852907000588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":169,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S0889852907000588"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2007.06.002","relation":{},"ISSN":["0889-8529"],"issn-type":[{"value":"0889-8529","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperthyroidism","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2007.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}